Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (342)	9/9/2007 4:26:33 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 360

Not entirely off topic... I saw a lecture by a Stanford research scientist regarding heart failure. They used gene expression of heart tissue from patients before and after they went on heart assist. The lab used microarrays to identify differential gene expression and teased out interesting pathways. Then they did a cellular assay and found a molecule which up (or down?) regulated four of the genetic pathways. They found four genes, which he said, was like finding the holy grail for heart failure. I think I have the basics of his lecture approximately right. Now they are moving on to using whole genome arrays. Although I don't recall the genes or the molecules mentioned, or the name of the PhD (It was Euan something with that odd spelling, I'll google for the lab another time), it was really nice to be able to follow the lecture--the jargon wasn't overwhelming. Gene Logic was right there with differential gene expression and genomics. I'm wistfully reflecting on years past--the promise of genomics. It does seem to pay off from time to time; certainly it is paying off at Stanford.